Single-center analysis of cardiac amyloidosis using 99mTc-HMDP imaging for diagnosis and evaluation after tafamidis treatment
Sign Up to like & getrecommendations! Published in 2024 at "Nuclear Medicine Communications"
DOI: 10.1097/mnm.0000000000001922
Abstract: Objective This study aimed to evaluate the diagnostic performance of 99mTc-hydroxymethylene diphosphonate (99mTc-HMDP) imaging for cardiac amyloidosis and to demonstrate changes in cardiac uptake of 99mTc-HMDP after tafamidis treatment. Methods Seventy-five patients with suspected cardiac… read more here.
Keywords: attr; hmdp imaging; tafamidis treatment; suvpeak ... See more keywords
Whole Body CD8+ T Cell PET Imaging in Patients with DLBCL before and during Anti-CD19 CAR T Cell Therapy
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-199474
Abstract: CAR T cell therapy (CART) has advanced the treatment of patients (pts) with refractory/relapsed diffuse large B-cell lymphoma (RR DLBCL), but long-term disease control eludes most recipients. Better clinical outcomes are associated with dense CD8+… read more here.
Keywords: cd8; car; cell; suvpeak ... See more keywords
What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours
Sign Up to like & getrecommendations! Published in 2019 at "EJNMMI Research"
DOI: 10.1186/s13550-019-0577-7
Abstract: BackgroundIn clinical routine, SUVmax and SUVpeak are most often used to determine the glucose metabolism in tumours by 18F-FDG PET/CT. Both metrics can be further normalised to SUVs in reference regions resulting in a SUV… read more here.
Keywords: suv metrics; reference region; reference; suvpeak ... See more keywords